Literature DB >> 30869558

Key Glycolytic Metabolites in Paralyzed Skeletal Muscle Are Altered Seven Days after Spinal Cord Injury in Mice.

Zachary A Graham1,2, Jacob A Siedlik3, Lauren Harlow1, Karim Sahbani1, William A Bauman1,4,2,5, Hesham A Tawfeek1,2, Christopher P Cardozo1,4,2,5.   

Abstract

Spinal cord injury (SCI) results in rapid muscle atrophy and an oxidative-to-glycolytic fiber-type shift. Those with chronic SCI are more at risk for developing insulin resistance and reductions in glucose clearance than able-bodied individuals, but how glucose metabolism is affected after SCI is not well known. An untargeted metabolomics approach was utilized to investigate changes in whole-muscle metabolites at an acute (7-day) and subacute (28-day) time frame after a complete T9 spinal cord transection in 20-week-old female C57BL/6 mice. Two hundred one metabolites were detected in all samples, and 83 had BinBase IDs. A principal components analysis showed the 7-day group as a unique cluster. Further, 36 metabolites were altered after 7- and/or 28-day post-SCI (p values <0.05), with 12 passing further false discovery rate exclusion criteria; of those 12 metabolites, three important glycolytic molecules-glucose and downstream metabolites pyruvic acid and lactic acid-were reduced at 7 days compared to those values in sham and/or 28-day animals. These changes were associated with altered expression of proteins associated with glycolysis, as well as monocarboxylate transporter 4 gene expression. Taken together, our data suggest an acute disruption of skeletal muscle glucose uptake at 7 days post-SCI, which leads to reduced pyruvate and lactate levels. These levels recover by 28 days post-SCI, but a reduction in pyruvate dehydrogenase protein expression at 28 days post-SCI implies disruption in downstream oxidation of glucose.

Entities:  

Keywords:  glycolysis; metabolomics; paralysis; skeletal muscle; spinal cord injury

Year:  2019        PMID: 30869558      PMCID: PMC6727471          DOI: 10.1089/neu.2018.6144

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  55 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Enzyme and size profiles in chronically inactive cat soleus muscle fibers.

Authors:  S C Graham; R R Roy; C Navarro; B Jiang; D Pierotti; S Bodine-Fowler; V R Edgerton
Journal:  Muscle Nerve       Date:  1992-01       Impact factor: 3.217

3.  Body-weight-support treadmill training improves blood glucose regulation in persons with incomplete spinal cord injury.

Authors:  Stuart M Phillips; Brian G Stewart; Douglas J Mahoney; Audrey L Hicks; Neil McCartney; Jason E Tang; Sarah B Wilkinson; David Armstrong; Mark A Tarnopolsky
Journal:  J Appl Physiol (1985)       Date:  2004-04-23

4.  Effect of long-term muscle paralysis on human single fiber mechanics.

Authors:  Laurent Malisoux; Cécile Jamart; Krystel Delplace; Henri Nielens; Marc Francaux; Daniel Theisen
Journal:  J Appl Physiol (1985)       Date:  2006-10-12

Review 5.  Carbohydrate and lipid metabolism in chronic spinal cord injury.

Authors:  W A Bauman; A M Spungen
Journal:  J Spinal Cord Med       Date:  2001       Impact factor: 1.985

6.  Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.

Authors:  Jun Xu; Gary Xiao; Chuck Trujillo; Vicky Chang; Lilia Blanco; Sean B Joseph; Sara Bassilian; Mohammed F Saad; Peter Tontonoz; W N Paul Lee; Irwin J Kurland
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

7.  Adaptations in metabolic capacity of rat soleus after paralysis.

Authors:  Jeffrey S Otis; Roland R Roy; V Reggie Edgerton; Robert J Talmadge
Journal:  J Appl Physiol (1985)       Date:  2003-10-17

8.  Long-term denervation in humans causes degeneration of both contractile and excitation-contraction coupling apparatus, which is reversible by functional electrical stimulation (FES): a role for myofiber regeneration?

Authors:  Helmut Kern; Simona Boncompagni; Katia Rossini; Winfried Mayr; Giorgio Fanò; Maria Elena Zanin; Marzena Podhorska-Okolow; Feliciano Protasi; Ugo Carraro
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

9.  Factors influencing body composition in persons with spinal cord injury: a cross-sectional study.

Authors:  Ann M Spungen; Rodney H Adkins; Charles A Stewart; Jack Wang; Richard N Pierson; Robert L Waters; William A Bauman
Journal:  J Appl Physiol (1985)       Date:  2003-08-08

10.  PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.

Authors:  Marco Sandri; Jiandie Lin; Christoph Handschin; Wenli Yang; Zoltan P Arany; Stewart H Lecker; Alfred L Goldberg; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

View more
  4 in total

1.  SS-31 does not prevent or reduce muscle atrophy 7 days after a 65 kdyne contusion spinal cord injury in young male mice.

Authors:  Zachary A Graham; Jennifer J DeBerry; Christopher P Cardozo; Marcas M Bamman
Journal:  Physiol Rep       Date:  2022-05

2.  EZH2 Mediates miR-146a-5p/HIF-1α to Alleviate Inflammation and Glycolysis after Acute Spinal Cord Injury.

Authors:  Shuangfei Ni; Bo Yang; Lei Xia; Huafeng Zhang
Journal:  Mediators Inflamm       Date:  2021-05-19       Impact factor: 4.711

3.  A 50 kdyne contusion spinal cord injury with or without the drug SS-31 was not associated with major changes in muscle mass or gene expression 14 d after injury in young male mice.

Authors:  Zachary A Graham; Jennifer J DeBerry; Christopher P Cardozo; Marcas M Bamman
Journal:  Physiol Rep       Date:  2021-02

4.  Oxygen transport kinetics underpin rapid and robust diaphragm recovery following chronic spinal cord injury.

Authors:  Philippa M Warren; Roger W P Kissane; Stuart Egginton; Jessica C F Kwok; Graham N Askew
Journal:  J Physiol       Date:  2020-11-22       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.